Canaccord Genuity Maintains Buy on Orthofix Medical, Lowers Price Target to $20
Benzinga Newsdesk 8 months ago
NewsPrice TargetAnalyst Ratings
Canaccord Genuity analyst Caitlin Burrows maintains Orthofix Medical (NASDAQ:OFIX) with a Buy and lowers the price target from $24 to $20.
Canaccord Genuity analyst Caitlin Burrows maintains Orthofix Medical (NASDAQ:OFIX) with a Buy and lowers the price target from $24 to $20.